{"id":"https://openalex.org/W2052586882","doi":"https://doi.org/10.1002/hup.723","title":"Efficacy and tolerability of quetiapine in patients with schizophrenia who switched from haloperidol, olanzapine or risperidone","display_name":"Efficacy and tolerability of quetiapine in patients with schizophrenia who switched from haloperidol, olanzapine or risperidone","publication_year":2005,"publication_date":"2005-09-21","ids":{"openalex":"https://openalex.org/W2052586882","doi":"https://doi.org/10.1002/hup.723","mag":"2052586882","pmid":"https://pubmed.ncbi.nlm.nih.gov/16175656"},"language":"en","primary_location":{"id":"doi:10.1002/hup.723","doi":"https://doi.org/10.1002/hup.723","is_oa":false,"landing_page_url":"https://doi.org/10.1002/hup.723","pdf_url":null,"source":{"id":"https://openalex.org/S154207414","display_name":"Human Psychopharmacology Clinical and Experimental","issn_l":"0885-6222","issn":["0885-6222","1099-1077"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Psychopharmacology: Clinical and Experimental","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086402839","display_name":"Ilkka Larmo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4388891872","display_name":"City of Helsinki","ror":"https://ror.org/03vdzkx92","country_code":"FI","type":"government","lineage":["https://openalex.org/I4388891872"]}],"countries":["FI"],"is_corresponding":true,"raw_author_name":"Ilkka Larmo","raw_affiliation_strings":["Keskinen Terveyskeskus, Auroran Psykiatrinen Osasto, Helsingin kaupunki, Finland. ilarmo@pp.htv.fi","Keskinen Terveyskeskus, Auroran Psykiatrinen Osasto, Helsingin kaupunki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Keskinen Terveyskeskus, Auroran Psykiatrinen Osasto, Helsingin kaupunki, Finland. ilarmo@pp.htv.fi","institution_ids":["https://openalex.org/I4388891872"]},{"raw_affiliation_string":"Keskinen Terveyskeskus, Auroran Psykiatrinen Osasto, Helsingin kaupunki, Finland","institution_ids":["https://openalex.org/I4388891872"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Andr\u00e9 de Nayer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andr\u00e9 de Nayer","raw_affiliation_strings":["Ho\u0302pital Ste-The\u0301re\u0300se, Belgium","H\u00f4pital Ste\u2010Th\u00e9r\u00e8se, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ho\u0302pital Ste-The\u0301re\u0300se, Belgium","institution_ids":[]},{"raw_affiliation_string":"H\u00f4pital Ste\u2010Th\u00e9r\u00e8se, Belgium","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035662657","display_name":"E. Windhager","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122076","display_name":"Klinikum Wels-Grieskirchen","ror":"https://ror.org/030tvx861","country_code":"AT","type":"healthcare","lineage":["https://openalex.org/I4210122076"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Elmar Windhager","raw_affiliation_strings":["Psychiatrische Klinik Wels, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatrische Klinik Wels, Austria","institution_ids":["https://openalex.org/I4210122076"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Irmansyah","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I29617571","display_name":"University of Indonesia","ror":"https://ror.org/0116zj450","country_code":"ID","type":"education","lineage":["https://openalex.org/I29617571"]}],"countries":["ID"],"is_corresponding":false,"raw_author_name":"Irmansyah","raw_affiliation_strings":["Department of Psychiatry, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia","institution_ids":["https://openalex.org/I29617571"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022431975","display_name":"Bernhard Lindenbauer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bernhard Lindenbauer","raw_affiliation_strings":["O. O. Landesnervenklinik Wagner-Jauregg, Linz, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"O. O. Landesnervenklinik Wagner-Jauregg, Linz, Austria","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060736364","display_name":"Hans Rittmannsberger","orcid":"https://orcid.org/0000-0002-6567-4677","observed_orcids":["https://orcid.org/0000-0002-6567-4677"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hans Rittmannsberger","raw_affiliation_strings":["O. O. Landesnervenklinik Wagner-Jauregg, Linz, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"O. O. Landesnervenklinik Wagner-Jauregg, Linz, Austria","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Thomas Platz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas Platz","raw_affiliation_strings":["A. O. Landes KH Klagenfurt, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"A. O. Landes KH Klagenfurt, Austria","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109942855","display_name":"AM Jones","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A. Martin Jones","raw_affiliation_strings":["Astrazeneca, Alderley Park, Macclesfield, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Astrazeneca, Alderley Park, Macclesfield, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5020983668","display_name":"Charles A. Altman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles Altman","raw_affiliation_strings":["AstraZeneca Pharmaceuticals, Wilmington, Delaware, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca Pharmaceuticals, Wilmington, Delaware, USA","institution_ids":["https://openalex.org/I4210150756"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5086402839"],"corresponding_institution_ids":["https://openalex.org/I4388891872"],"apc_list":{"value":4030,"currency":"USD","value_usd":4030},"apc_paid":null,"fwci":1.8441,"has_fulltext":false,"cited_by_count":29,"citation_normalized_percentile":{"value":0.83980446,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"20","issue":"8","first_page":"573","last_page":"581"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/quetiapine","display_name":"quetiapine","score":1.0},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9549999833106995},{"id":"https://openalex.org/keywords/antipsychotic-switching","display_name":"antipsychotic switching","score":0.9290000200271606},{"id":"https://openalex.org/keywords/haloperidol","display_name":"haloperidol","score":0.9919999837875366},{"id":"https://openalex.org/keywords/olanzapine","display_name":"olanzapine","score":1.0},{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":1.0},{"id":"https://openalex.org/keywords/antipsychotic-monotherapy","display_name":"antipsychotic monotherapy","score":0.7549999952316284},{"id":"https://openalex.org/keywords/positive-and-negative-syndrome-scale","display_name":"PANSS","score":0.597000002861023},{"id":"https://openalex.org/keywords/extrapyramidal-symptoms","display_name":"extrapyramidal symptoms","score":0.9490000009536743},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.6010000109672546}],"concepts":[{"id":"https://openalex.org/C2780634440","wikidata":"https://www.wikidata.org/wiki/Q408535","display_name":"Quetiapine","level":3,"score":0.9544309973716736},{"id":"https://openalex.org/C2776619155","wikidata":"https://www.wikidata.org/wiki/Q201872","display_name":"Olanzapine","level":3,"score":0.9170361757278442},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8833335638046265},{"id":"https://openalex.org/C2780057945","wikidata":"https://www.wikidata.org/wiki/Q412443","display_name":"Risperidone","level":3,"score":0.8406332731246948},{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.6346142888069153},{"id":"https://openalex.org/C2911140283","wikidata":"https://www.wikidata.org/wiki/Q408535","display_name":"Quetiapine Fumarate","level":5,"score":0.5723194479942322},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.5401008129119873},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.5062426924705505},{"id":"https://openalex.org/C2781353949","wikidata":"https://www.wikidata.org/wiki/Q3271533","display_name":"Dopamine antagonist","level":4,"score":0.48794811964035034},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4840540289878845},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.45839014649391174},{"id":"https://openalex.org/C67761136","wikidata":"https://www.wikidata.org/wiki/Q2105849","display_name":"Post-hoc analysis","level":2,"score":0.4225974977016449},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4155440032482147},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.37259772419929504},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.35774195194244385},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.315717875957489},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.26511797308921814},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.16090017557144165},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069348","descriptor_name":"Quetiapine Fumarate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077152","descriptor_name":"Olanzapine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003987","descriptor_name":"Dibenzothiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006220","descriptor_name":"Haloperidol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/hup.723","doi":"https://doi.org/10.1002/hup.723","is_oa":false,"landing_page_url":"https://doi.org/10.1002/hup.723","pdf_url":null,"source":{"id":"https://openalex.org/S154207414","display_name":"Human Psychopharmacology Clinical and Experimental","issn_l":"0885-6222","issn":["0885-6222","1099-1077"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Psychopharmacology: Clinical and Experimental","raw_type":"journal-article"},{"id":"pmid:16175656","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16175656","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human psychopharmacology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W132249558","https://openalex.org/W1922322992","https://openalex.org/W1967102579","https://openalex.org/W1967511280","https://openalex.org/W1969306344","https://openalex.org/W1971236819","https://openalex.org/W1982134688","https://openalex.org/W1998824580","https://openalex.org/W2029832366","https://openalex.org/W2033858169","https://openalex.org/W2035977341","https://openalex.org/W2056838635","https://openalex.org/W2060802427","https://openalex.org/W2067763161","https://openalex.org/W2086479492","https://openalex.org/W2090191759","https://openalex.org/W2093470593","https://openalex.org/W2096635847","https://openalex.org/W2097250781","https://openalex.org/W2111083453","https://openalex.org/W2124201150","https://openalex.org/W2134007137","https://openalex.org/W2137959682","https://openalex.org/W2141441326","https://openalex.org/W2160802754","https://openalex.org/W2162089381","https://openalex.org/W2167600992","https://openalex.org/W2167670100","https://openalex.org/W2168513289","https://openalex.org/W2471233225","https://openalex.org/W2522806337","https://openalex.org/W4229754189"],"related_works":["https://openalex.org/W2124201150","https://openalex.org/W2146813353","https://openalex.org/W2091054476","https://openalex.org/W1970566540","https://openalex.org/W2784837940","https://openalex.org/W2041473913","https://openalex.org/W1987559635","https://openalex.org/W2162089381","https://openalex.org/W2113008214","https://openalex.org/W2141441326"],"abstract_inverted_index":{"A":[0],"post":[1],"hoc":[2],"analysis":[3],"of":[4,72,120,191],"the":[5,14,79,86,94,98,169],"SPECTRUM":[6],"trial":[7],"was":[8,74,196],"carried":[9],"out":[10],"to":[11,23,52,102,183],"evaluate":[12],"whether":[13,192],"improvements":[15,106,142],"in":[16,78,85,93,109,117,146,166],"efficacy":[17,186],"and":[18,58,89,123,132,171,187],"tolerability":[19,188],"gained":[20],"on":[21,168],"switching":[22],"quetiapine":[24,51,73,103,184],"occurred":[25],"consistently":[26],"for":[27,64,125,150,173],"patients":[28,126,151],"previously":[29,127],"treated":[30,128],"with":[31,50,112,129],"either:":[32],"haloperidol":[33,80],"(n":[34,38,43],"=":[35,39,44],"43);":[36],"olanzapine":[37,87,131,198],"66);":[40],"or":[41,199],"risperidone":[42,95],"55)":[45],"monotherapy.":[46],"Patients":[47],"were":[48,143,163],"initiated":[49],"400":[53],"mg/day":[54,77,84,92],"over":[55],"7":[56],"days,":[57],"then":[59],"flexibly":[60],"dosed":[61],"(300-750":[62],"mg/day)":[63],"11":[65],"weeks.":[66],"The":[67],"mean":[68,115],"(SD)":[69],"modal":[70],"dose":[71],"501":[75],"(138)":[76],"subgroup,":[81],"472":[82],"(147)":[83],"subgroup":[88,96],"485":[90],"(141)":[91],"at":[97,154],"study":[99],"endpoint.":[100],"Switching":[101,182],"induced":[104],"significant":[105,164],"from":[107],"baseline":[108,155],"PANSS":[110],"scores,":[111,148],"least":[113],"square":[114],"changes":[116],"total":[118],"scores":[119],"-32.5,":[121],"-15.4,":[122],"-18.5":[124],"haloperidol,":[130,197],"risperidone,":[133],"respectively,":[134],"(all":[135,156,176],"p":[136,157,177],"<":[137,158,178],"0.001":[138,159,179],"vs":[139,160,180],"baseline).":[140,161,181],"Significant":[141],"also":[144],"noted":[145],"CDSS":[147],"particularly":[149],"clinically":[152],"depressed":[153],"There":[162],"reductions":[165],"EPS":[167],"SAS":[170],"BAS":[172],"all":[174],"subgroups":[175],"produced":[185],"benefits":[189],"regardless":[190],"their":[193],"previous":[194],"antipsychotic":[195],"risperidone.":[200]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}